Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
The British Journal of Dermatology
|
February 19, 2010
Segmental pigmentation disorder
M Hogeling, I J Frieden
STAR Protocols
|
October 8, 2021
CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones
Roos Houtsma, Shanna M Hogeling, Jan Jacob Schuringa
Dermatology Online Journal
|
January 11, 2021
Recent advances in hidradenitis suppurativa in pediatrics
C W Rundle, K N Price, M Hogeling, et al.
Analytical Biochemistry
|
March 24, 2019
Quantification of proteins in whole blood, plasma and DBS, with element-labelled antibody detection by ICP-MS
Shanna M Hogeling, Michael T Cox, Robert M Bradshaw, et al.
Haematologica
|
December 11, 2025
Potent synergy of DHODH and SREBP inhibition in acute myeloid leukemia via disruption of cholesterol and lipid metabolism
Shanna M Hogeling, Dominique Sternadt, Nikita La Rose, et al.
Haematologica
|
December 20, 2024
Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia
Shanna M Hogeling, Duy Minh Lê, Nikita La Rose, et al.
Nucleic Acids Research
|
June 11, 2026
Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiation
Fatemeh Mojallali, Alessandra De Meis, Sinne G Alkema, et al.
Blood Advances
|
September 20, 2021
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones
Roos Houtsma, Nisha K van der Meer, Kees Meijer, et al.
Blood Advances
|
October 31, 2025
Metformin induces ferroptosis associated with lipidomic remodeling in AML
Dominique Sternadt, Diego A Pereira-Martins, Prodromos Chatzikyriakou, et al.
Iscience
|
June 11, 2021
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia
Henny Maat, Tjerk Jan Atsma, Shanna M Hogeling, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
The British Journal of Dermatology
|
February 19, 2010
Segmental pigmentation disorder
M Hogeling, I J Frieden
STAR Protocols
|
October 8, 2021
CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones
Roos Houtsma, Shanna M Hogeling, Jan Jacob Schuringa
Dermatology Online Journal
|
January 11, 2021
Recent advances in hidradenitis suppurativa in pediatrics
C W Rundle, K N Price, M Hogeling, et al.
Analytical Biochemistry
|
March 24, 2019
Quantification of proteins in whole blood, plasma and DBS, with element-labelled antibody detection by ICP-MS
Shanna M Hogeling, Michael T Cox, Robert M Bradshaw, et al.
Haematologica
|
December 11, 2025
Potent synergy of DHODH and SREBP inhibition in acute myeloid leukemia via disruption of cholesterol and lipid metabolism
Shanna M Hogeling, Dominique Sternadt, Nikita La Rose, et al.
Haematologica
|
December 20, 2024
Bleximenib, the novel menin-KMT2A inhibitor JNJ-75276617, impairs long-term proliferation and immune evasion in acute myeloid leukemia
Shanna M Hogeling, Duy Minh Lê, Nikita La Rose, et al.
Nucleic Acids Research
|
June 11, 2026
Sustained PRC1.1 activity preserves gene repression independently of PRC2.2 and restrains leukemic cell differentiation
Fatemeh Mojallali, Alessandra De Meis, Sinne G Alkema, et al.
Blood Advances
|
September 20, 2021
CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones
Roos Houtsma, Nisha K van der Meer, Kees Meijer, et al.
Blood Advances
|
October 31, 2025
Metformin induces ferroptosis associated with lipidomic remodeling in AML
Dominique Sternadt, Diego A Pereira-Martins, Prodromos Chatzikyriakou, et al.
Iscience
|
June 11, 2021
The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia
Henny Maat, Tjerk Jan Atsma, Shanna M Hogeling, et al.
Page
of 2